Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2023-03-14 00:00:00 ET · period of report 2023-03-10 · accession 0001171843-23-001684 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-14 | 2023-03-10 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | F - Tax | $26.10 | -13.2K | 100.6K | -12% | -$344.8K |
| D | 2023-03-14 | 2023-03-10 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +30.1K | 113.8K | +36% | $0 |
| D | 2023-03-14 | 2023-03-10 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | -30.1K | 60.1K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-10 | F | D | 13,211 | $26.10 | 100,580 | D | — | — | (F2) Reflects an aggregate of 13,211 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2023. (F3) Reflects the closing price of ANIK common stock on March 10, 2023, the trading day immediately preceding the date on which the vesting of RSUs gave rise to tax withholding obligations. |
| 2 | Common | Common Stock | 2023-03-10 | M | A | 30,060 | $0.00 | 113,791 | D | — | — | (F1) Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 11, 2022. |
| 3 | Derivative | Restricted Stock Unit | 2023-03-10 | M | D | 30,060 | $0.00 | 60,119 | D | $0.00 · — to — | 30,060 Common Stock | (F5) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023. |